Denosumab improves density and strength parameters as measured by QCT of the radius in postmenopausal women with low bone mineral density.
about
Bone strength and management of postmenopausal fracture risk with antiresorptive therapies: considerations for women's health practiceNew imaging modalities in boneEffects of denosumab on bone density, mass and strength in women with postmenopausal osteoporosis.Infections in postmenopausal women with osteoporosis treated with denosumab or placebo: coincidence or causal association?Noninvasive imaging of bone microarchitecture.Role of DNA methylation in the regulation of the RANKL-OPG system in human bone.Persistence, adherence, and medication-taking behavior in women with postmenopausal osteoporosis receiving denosumab in routine practice in Germany, Austria, Greece, and Belgium: 12-month results from a European non-interventional studyRelationship between bone mineral density changes with denosumab treatment and risk reduction for vertebral and nonvertebral fractures.Further reductions in nonvertebral fracture rate with long-term denosumab treatment in the FREEDOM open-label extension and influence of hip bone mineral density after 3 yearsEffect of denosumab on bone mineral density and biochemical markers of bone turnover: 8-year results of a phase 2 clinical trialThe contribution of cortical and trabecular tissues to bone strength: insights from denosumab studiesLeast significant changes and monitoring time intervals for high-resolution pQCT-derived bone outcomes in postmenopausal women.The clinical use of denosumab for the management of low bone mineral density in postmenopausal women.New developments in the treatment of osteoporosis.Denosumab, a RANK ligand inhibitor, for postmenopausal women with osteoporosis.Effects of denosumab on cortical and trabecular microarchitecture: evidences from clinical studies.Response to: 'Denosumab, cortical bone and bone erosion in rheumatoid arthritis' by Rossini et al.Estimation of in vivo cortical bone thickness using ultrasonic waves.Tibial and fibular mid-shaft bone traits in young and older sprinters and non-athletic men.Interleukin-19 blockade attenuates collagen-induced arthritis in rats.The challenges of diagnosing osteoporosis and the limitations of currently available tools.
P2860
Q28066185-CAD701C0-3061-4C41-AE1B-723531E60455Q34975985-D998697B-43B8-441C-A58C-EC3D33D36B18Q35589102-5772A012-06FD-4379-A0EE-ACE2BA3A1B70Q35643989-75E19507-9495-4275-ABC5-997C6B252AB2Q35703263-3F1A5CFC-2C0B-48D3-8ED8-F52891E60A32Q35916106-9C15828B-DC5D-4088-92FB-09EE1579A4F1Q36073613-35906ACB-5AAE-494C-A587-5CFF84F8DDFDQ36153174-6DE9F718-CB39-48BF-99C9-B1C59340B97AQ36309349-2DD99B0F-7605-420B-9DF4-BF632A195CE4Q36508404-D8CBB759-5636-45D2-B41E-84D1800D4EB5Q37008054-C0789085-AA11-4A2C-99C5-2EFE7A08BA1BQ37465170-08420356-0BA0-4282-8316-F964136ECB2AQ38006918-51E53D9F-1E22-4417-B6E9-E87C7157EE58Q38014515-0DE84852-7916-40AB-B386-158562104046Q38029995-2520D655-7557-4964-B76E-2C24EA2F067BQ38138867-52DBBD23-DEEE-4B0B-A24B-41BB7389877FQ46559560-DFC60CD2-0601-4FF3-AEF3-2370D331EE5AQ51641746-C4F6858C-2956-4FA3-BC94-059EBCF9F72FQ53063139-DDE88E40-03FD-4D95-8D0E-E92FFDBDE007Q54361910-DB52B2A8-08A7-432E-9ABD-28BFEB338DDFQ55113719-058202D7-2EA1-421D-9E97-F05EE524276B
P2860
Denosumab improves density and strength parameters as measured by QCT of the radius in postmenopausal women with low bone mineral density.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Denosumab improves density and ...... with low bone mineral density.
@ast
Denosumab improves density and ...... with low bone mineral density.
@en
type
label
Denosumab improves density and ...... with low bone mineral density.
@ast
Denosumab improves density and ...... with low bone mineral density.
@en
prefLabel
Denosumab improves density and ...... with low bone mineral density.
@ast
Denosumab improves density and ...... with low bone mineral density.
@en
P2093
P1433
P1476
Denosumab improves density and ...... with low bone mineral density.
@en
P2093
A J Kivitz
C Libanati
D A Hanley
H K Genant
P304
P356
10.1016/J.BONE.2010.04.594
P577
2010-04-22T00:00:00Z